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Dedication
Thi it i d di t d t th f Ds s e s e ca e  o e memory o  anny 
Pollak, who lost his life to 
Hemangioendothelioma (a rare vascular    
cancer), after a 10 year struggle.
He fought his battle with dignity and courage       , 
lived every day of his life to the fullest, and 
achieved so much  .
He will live forever in the hearts and memories 
of his family  .
Cynthia and Peter Pollak, September 2008
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Introduction
• CART-wheel serves consumers, researchers 
and clinicians
• Clinically vetted information about rare 
tumours
• Patient support site
Q ti i t ll t ti t i f ti• ues onna re o co ec  pa en  n orma on 
about their condition and treatment
Th Diffi lti f B i ‘R ’e cu es o  e ng are
• Rare cancers account for up to 20% of 
cancers diagnosed each year
• They account for 31% annual cancer related 
deaths
• More than 500 types of rare tumours
• No single institution can collect a significant       
cohort of any one type
CART wheel can also serve patients with rare• -        
sub-types of more common cancers
Ethically Approved Registry  
• Cynthia Pollak, mother of a patient with       
hemangiodenothelioma, searched for 
information and found very little
• Started http://www.heardsupport.org/ and 
collected over 250 participants in 10 years
• After 10 years Cynthia Pollak appealed to 
cancer research community for help
• Dr Clare Scott responded by applying and 
obtaining ethics approval for collecting the 
data and a special purpose patient consent 
form
Design of the CART-wheel 
Website
• Information
– FAQ lists
– Information Pages
– Links
– Aggregated results from CART-wheel data
• Questionnaire
– Self-registration
– Consent
– Ability to return to questionnaire at anytime
• Support
– Moderated User Forum
– email address for further information
Technology
• Microsoft SQL Server 2005 backend 
repository
• .NET framework 2.0, ASP, C#, nHibernate
• IIS v6.0 
• Windows 2003 Server
www yetanotherforum net• . .
• Hosted at Melbourne Health
Potential Support for Patients
• Moderated interactive forum  
• Geographically isolated can “meet at CART-
heel”w
• Reliable medically vetted information
• Links to related websites
Potential Support for Research
• Growth of cohort, hopefully leading to large 
h i t t d diff t t fenoug  s ze o s u y eren  ypes o  rare 
tumour
• Other types of research possible with consent 
of participants
• CART-wheel data is made available by 
BioGrid Australia infrastructure
Research via BioGrid  
• www biogrid org au. . .
• De-identify and link patient information
• Federate CART wheel data with other clinical -      
and research databases
• Access control to all participating databases     
• Provision of search and statistical analysis 
tools
• Contact CART-wheel participants to form a 
cohort if ethics approved consented and   ,   
applicable
Conclusion
• Clarity of function and purpose of CART      -
wheel grew with development
B i i t f d t ll ti• eg nn ng s ages o  a a co ec on
• Expectation that CART-wheel will yield 
research studies into rare tumours otherwise 
not contemplated
• Want to see CART-wheel become the 
foundation for ongoing research and 
discovery in the field of rare tumour aetiology 
and treatment
